早在2020年,传学Proteintech 与 Active Motif 就已达成战略合作,善人通过 Proteintech的体组销售渠道在中国地区销售 Active Motif 旗下全线产品。此次投资,计划是战资表专两家公司战略合作的升级。基于此前的良好合作,双方都表示,非常期待今后在亚太地区进一步发展合作关系。
Proteintech首席执行官李建勋博士表示:“与 Active Motif 的深度合作,促进共同开发新的产品,从而更好地服务我们的客户。这项投资也进一步提升了 Proteintech 的战略优势,即通过提供一流的抗体产品更好地服务于科学研究领域。”
"Working more closely with Active Motif will enable us to serve our customers better through collaborations and the development of new products. This investment adds to Proteintech's strategy to provide best in class antibody, nanobody and recombinant protein products for the greater benefit of research and discovery."
—Dr. Jason Li, CEO of Proteintech
Active Motif 总裁兼首席执行官 Ted DeFrank 表示:“我们一直在寻找能够帮助 Active Motif 扩充和延展现有产品与服务的盟友。作为战略合作伙伴,Proteintech 不仅为公司注入了资金,更为我们提供了获得高质量抗体和宽广销售渠道的机会。”
"We have been in search of an ally that can add breadth and complement our current portfolio of products and services. Proteintech, as a strategic partner, provides the company with not only a cash infusion but also access to high-value antibodies and additional distribution channels."